Histidine decarboxylase is identified as a potential biomarker of intestinal mucosal injury in patients with acute intestinal obstruction

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1323-1337

  Yang, Jian Jun ^a   Ma, Yan Lei ^a   Zhang, Peng ^a   Chen, Hong Qi ^a   Liu, Zhi Hua ^a   Qin, Huan Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; CLAUDIN 1; HISTIDINE DECARBOXYLASE; PROTEIN ZO1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; INTESTINE OBSTRUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; UPREGULATION; WESTERN BLOTTING;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT DYES; HISTIDINE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINAL OBSTRUCTION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 82855172208     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00107     Document Type: Article

References (67)

1. Bruewer M, Samarin S, Nusrat A. (2006) Inflammatory bowel disease and the apical junctional complex. Ann. N. Y. Acad. Sci. 1072:242-252.
2. Gurleyik G, et al. (2003) Prostaglandins E1 and E2 analogues ameliorate mucosal injury secondary to distal colonic obstruction. J. Invest. Surg. 16:283-8.
3. Chang T, Lu R, Tsai L. (2001) Glutamine ameliorates mechanical obstruction-induced intestinal injury. J. Surg. Res. 95:133-40.
4. Costantini TW, et al. (2009) Role of p38 MAPK in burn-induced intestinal barrier breakdown. J. Surg. Res. 156:64-69.
5. de Haan JJ, et al. (2009) Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study. Crit. Care. 13:R86.
6. Jin W, et al. (2009) Transcription factor Nrf2 plays a pivotal role in protection against traumatic brain injury-induced acute intestinal mucosal injury in mice. J. Surg. Res. 157:251-60.
7. Derikx JP, et al. (2008) Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One. 3:e3428.
8. Guan Y, Worrell RT, Pritts TA, Montrose MH. (2009) Intestinal ischemia-reperfusion injury: reversible and irreversible damage imaged in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 297:G187-96.
9. Tunc T, et al. (2009) Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J. Surg. Res. 155:210-6.
10. Zhang XP, Zhang J, Song QL, Chen HQ. (2007) Mechanism of acute pancreatitis complicated with injury of intestinal mucosa barrier. J. Zhejiang Univ. Sci. B. 8:888-95.
11. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. (2003) Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J. Gastrointest. Surg. 7:26-36.
12. Zhang X, et al. (2008) Study of the protective effects of dexamethasone on ileum mucosa injury in rats with severe acute pancreatitis. Pancreas. 37:e74-82.
13. Grotz MR, et al. (1999) Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann. Surg. 229:478-86.
14. Faries PL, Simon RJ, Martella AT, Lee MJ, Machiedo GW. (1998) Intestinal permeability correlates with severity of injury in trauma patients. J. Trauma. 44:1031-6.
15. Swank GM, Deitch EA. (1996) Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J. Surg. 20:411-7.
16. Jin W, et al. (2008) Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. Cytokine. 44:135-40.
17. Sarr MG, Bulkley GB, Zuidema GD. (1983) Pre-operative recognition of intestinal strangulation obstruction: prospective evaluation of diagnostic capability. Am. J. Surg. 145:176-82.
18. Leffall LD, Syphax B. (1970) Clinical aids in strangulation intestinal obstruction. Am. J. Surg. 120:756-9.
19. Murray MJ, Gonze MD, Nowak LR, Cobb CF. (1994) Serum D(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am. J. Surg. 167:575-8.
20. Poeze M. (1999) D-lactate as an early marker of intestinal ischaemia after ruptured abdominal aortic aneurysm repair: reply. Br. J. Surg. 86:712.
21. Assadian A, et al. (2006) Plasma D-lactate as a potential early marker for colonic ischaemia after open aortic reconstruction. Eur. J. Vasc. Endovasc. Surg. 31:470-4.
22. Delaney CP, O'Neill S, Manning F, Fitzpatrick JM, Gorey TF. (1999) Plasma concentrations of glutathione S-transferase isoenzyme are raised in patients with intestinal ischaemia. Br. J. Surg. 86:1349-53.
23. Gearhart SL, et al. (2003) Prospective assessment of the predictive value of alpha-glutathione S-transferase for intestinal ischemia. Am. Surg. 69:324-9.
24. Cronk DR, et al. (2006) Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small intestinal obstruction. Curr. Surg. 63:322-5.
25. Mittak M, Karlik T. (2008) Diagnostics of intestinal ischemia: influence of surgery on plasma levels of I-FABP as the marker of enterocyte injury. Rozhl. Chir. 87:16-20.
26. Acosta S, Nilsson TK, Bjorck M. (2004) D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br. J. Surg. 91:991-4.
27. Icoz G, et al. (2006) Is D-dimer a predictor of strangulated intestinal hernia? World J. Surg. 30:2165-9.
28. Polk JD, et al. (2008) Clinical utility of the cobaltalbumin binding assay in the diagnosis of intestinal ischemia. J. Trauma. 64:42-5.
29. Bounous G, Echave V, Vobecky SJ, Navert H, Wollin A. (1984) Acute necrosis of the intestinal mucosa with high serum levels of diamine oxidase. Dig. Dis. Sci. 29:872-4.
30. Herrera Hernández MF, et al. (1989) Immunoreactive urinary thromboxane B2 in experimental mesenteric thrombosis in dogs. Rev. Invest. Clin. 41:123-7.
31. Tyers M, Mann M. (2003) From genomics to proteomics. Nature. 422:193-7.
32. O'Farrell PH. (1975) High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250:4007-21.
33. Unlu M, Morgan ME, Minden JS. (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 18:2071-7.
34. Tonge R, et al. (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics. 1:377-96.
35. Van den Bergh G, Arckens L. (2004) Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr. Opin. Biotechnol. 15:38-43.
36. Yan JX, et al. (2002) Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics. 2:1682-98.
37. Zhou G, et al. (2002) 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics. 1:117-24.
38. Ma Y, et al. (2009) Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach. Electrophoresis. 30:2591-9.
39. Rodriguez-Pineiro AM, Blanco-Prieto S, Sanchez-Otero N, Rodríguez-Berrocal FJ, de la Cadena MP. (2010) On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion. J. Proteomics. 73:1511-22.
40. Zubaidah RM, et al. (2008) 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics. 8:5086-96.
41. Zipplies JK, et al. (2010) Kininogen in autoimmune uveitis: decrease in peripheral blood stream versus increase in target tissue. Invest. Ophthalmol. Vis. Sci. 51:375-82.
42. Tumani H, et al. (2009) Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid. J. Neuroimmunol. 214:109-12.
43. English JA, Dicker P, Focking M, Dunn MJ, Cotter DR. (2009) 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics. 9:3368-82.
44. Grzeskowiak JK, et al. (2009) 2-D DIGE to expedite downstream process development for human monoclonal antibody purification. Protein Expr. Purif. 66:58-65.
45. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP. (2010) Proteomics of drug resistance in Candida glabrata biofilms. Proteomics. 10:1444-54.
46. Faca VM, et al. (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med. 5:e123.
47. Ma YL, et al. (2009) Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology. J. Proteome Res. 8:4525-35.
48. Ma Y, et al. (2009) Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol. Cell Proteomics. 8:1878-90.
49. Liu W, et al. (2010) Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol. Biol. Rep. 37:3207-16.
50. Peng J, et al. (2009) A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis. Electrophoresis. 30:2976-87.
51. Thomas CE, Sexton W, Benson K, Sutphen R, Koomen J. (2010) Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiol. Biomarkers Prev. 19:953-9.
52. Gamagedara S, Gibbons S, Ma Y. (2011) Investigation of urinary pteridine levels as potential biomarkers for noninvasive diagnosis of cancer. Clin. Chim. Acta. 412:120-8.
53. Alban A, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics. 3:36-44.
54. Berg DJ, et al. (1996) Enterocolitis and colonic cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98:1010-20.
55. Martin B. (2007) Prevention of gastrointestinal complications in the critically ill patient. ASACN Adv. Crit. Care. 18:158-66.
56. Wang N, et al. (2010) Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients. Scand. J. Gastroenterol. 45:191-9.
57. Roxas JL, et al. (2010) Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab. Invest. 90:1152-68.
58. McCall IC, et al. (2009) Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol. Appl. Pharmacol. 241:61-70.
59. Qin H, Zhang Z, Hang X, Jiang Y. (2009) L. plantarum prevents enteroinvasive Escherichia coliinduced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 9:63.
60. Perkins NJ, Schisterman EF. (2006) The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am. J. Epidemiol. 163:670-5.
61. Schisterman EF, Faraggi D, Reiser B. (2004) Adjusting the generalized ROC curve for covariates. Stat. Med. 23:3319-31.
62. Evennett NJ, Petrov MS, Mittal A, Windsor JA. (2009) Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J. Surg. 33:1374-83.
63. Handley SA, Dube PH, Miller VL. (2006) Histamine signaling through the H-2 receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc. Natl. Acad. Sci. U S A. 103:9268-73.
64. Kahlson G, Rosengren E. (1968) New approaches to the physiology of histamine. Physiol. Rev. 48:155-96.
65. Fujimoto K, et al. (1992) Histamine and histidine decarboxylase are correlated with mucosal repair in rat small intestine after ischemia-reperfusion. J. Clin. Invest. 89:126-33.
66. Mei Q, Sundler F. (1999) Local downregulation of enterochromaffin-like cell histamine formation in ulcer healing: a study in rats. Digestion. 60:227-37.
67. Wu ZD, Wu ZH. (2004) Surgery. Beijing, China; People's Medical Publishing House.